Khiron Life SciencesKHRNF

13F holders, Q3 2025 (September 30)
1holders
1new positions
1sold out
$0.00avg. 13F price*

At the end of Q3 2025, 1 institutions reported holding Khiron Life Sciences Corp. (KHRNF) in their 13F filings, unchanged from Q2 2025. 1 opened new positions and 1 sold out. The largest holder was FNY Investment Advisers, LLC ($0).

Company
Khiron Life Sciences Corp.
CUSIP
49374L306
Latest filing quarter
Q4 2025

History

Number of 13F holders

01 Q1 2024: 1Q1 2024Q2 2024: 1Q2 2024Q3 2024: 1Q3 2024Q4 2024: 1Q4 2024Q2 2025: 1Q2 2025Q3 2025: 1Q3 2025Q4 2025: 1Q4 2025

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions1$0
Exits1$0

All 13F filers, Q2 2025 → Q3 2025: 1,000 shares bought and 8,740 shares sold, net −7,740 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 1 holders

FNY Investment Advisers, LLC 0.00% New 1,000 $0

"% of holder's portfolio" is KHRNF's weight in each manager's 13F, not the share of Khiron Life Sciences Corp. the manager owns.